Mediprint® ophthalmics announces promising results from its sight-2 phase 2b group 1 clinical study

San diego--(business wire)--mediprint® ophthalmics announces promising results from its sight-2 phase 2b group 1 clinical study.

GPI Ratings Summary

GPI Quant Ranking